Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial-Reference-Cited by-同舟云学术

Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial

Published:2021-01 Issue:1 Volume:9 Page:21-32
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Cunningham Steve,Piedra Pedro A,Martinon-Torres Federico,Szymanski Henryk,Brackeva Benedicte,Dombrecht Evelyne,Detalle Laurent,Fleurinck Carmen,Cunningham Steve,Piedra Pedra A,Verhulst Stijn,Matthijs Inge,Proesmans Marijke,Goetghebuer Tessa,Bosheva Miroslava,Dosev Svilen,Nikolova Olga,Chakarova Petranka,Wu Hupat Elba,Mesa Monsalve Juan,Turkalj Mirjana,Mesaric Antoncic Natasa,Tesovic Goran,SIPL Mirna,Kljaic Bukvic Blazenka,Ivkovic-Jurekovic Irena,Cicak Biserka,Skalova Sylva,Horneff Gerd,Vogelberg Christian,Gacs Éva,Kalocsai Krisztina,Madarasi Anna,Kovacs Lajos,Novak Zoltan,Bene Zsolt,Ashkenazi Shai,Goldbart Aviv,Bentur Lea,Kolosa Nadezda,Gardovska Dace,Khaw Poh Guan,Toh Teck Hock,De Bruyne Jessie Anne,Tan Kah Kee,Alberto Edison,Sablan Benjamin, Junior,de Leon Anjanette,Szymanski Henryk,Repko Miroslav,Kralinsky Karol,Salamanca de la Cueva Ignacio,Rodrigo Gonzalo de Liria Carlos,Martinón-Torres Federico,Cedena Romero María Pilar,Monteagudo Montesinos Emilio,Teeratakulpisarn Jamaree,Puthanakit Thanyawee,Oberdorfer Peninnah,Warachit Boonyarat,Brackeva Benedicte,Dombrecht Evelyne,Detalle Laurent,Fleurinck Carmen

Funder

Sanofi China Investment Company

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference40 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study;Shi;Lancet,2017

2. Viral bronchiolitis in children;Meissner;N Engl J Med,2016

3. Determining the burden of respiratory syncytial virus disease: the known and the unknown;Karron;Lancet,2017

4. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study;O'Brien;Lancet,2019

5. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children;Ventre;Cochrane Database Syst Rev,2007

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies;European Journal of Pharmaceutics and Biopharmaceutics;2024-02

2. A molecular perspective for the development of antibodies against the human respiratory syncytial virus;Antiviral Research;2024-02

3. Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants;Nature Communications;2024-01-29

4. Current state and challenges in respiratory syncytial virus drug discovery and development;Antiviral Research;2024-01

5. Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children;World Journal of Pediatrics;2023-12-08